AutoZone price target raised to $1320 from $1300 at Wedbush

Periodicals

Both AT&T (T) and…

ShowHide Related Items >>

T AT&T
$27.94 /

-0.575 (-2.02%)

VZ Verizon
$58.97 /

-0.85 (-1.42%)

TMUS T-Mobile
$109.00 /

-3.44 (-3.06%)

T AT&T
$27.94 /

-0.575 (-2.02%)

08/31/20
Fly Intel: Top five analyst downgrades
08/31/20 Scotiabank
Scotiabank downgrades AT&T to Underperform on spectrum costs, share losses
08/31/20 Scotiabank
AT&T downgraded to Underperform from Sector Perform at Scotiabank
07/24/20 RBC Capital
AT&T price target lowered to $32 from $38 at RBC Capital
VZ Verizon
$58.97 /

-0.85 (-1.42%)

09/22/20 Roth Capital
Sequans article ‘steeped in ignorance’ brings opportunity, says Roth Capital
09/15/20 Bernstein
Verizon acquisition of Tracfone surprising but positive, says Bernstein
09/15/20 Oppenheimer
Verizon plans to acquire Tracfone positive for wireless growth, says Oppenheimer
09/08/20
Fly Intel: Top five analyst upgrades
TMUS T-Mobile
$109.00 /

-3.44 (-3.06%)

08/31/20
Fly Intel: Top five analyst initiations
08/31/20 Scotiabank
Scotiabank starts T-Mobile at Outperform, calls top pick in U.S. coverage
08/31/20 Scotiabank
Scotiabank downgrades AT&T to Underperform on spectrum costs, share losses
08/31/20 Scotiabank
T-Mobile initiated with an Outperform at Scotiabank
T AT&T
$27.94 /

-0.575 (-2.02%)

VZ Verizon
$58.97 /

-0.85 (-1.42%)

TMUS T-Mobile
$109.00 /

-3.44 (-3.06%)

T AT&T
$27.94 /

-0.575 (-2.02%)

VZ Verizon
$58.97 /

-0.85 (-1.42%)

TMUS T-Mobile
$109.00 /

-3.44 (-3.06%)

T AT&T
$27.94 /

-0.575 (-2.02%)

VZ Verizon
$58.97 /

-0.85 (-1.42%)

TMUS T-Mobile
$109.00 /

-3.44 (-3.06%)

T AT&T
$27.94 /

-0.575 (-2.02%)

VZ Verizon
$58.97 /

-0.85 (-1.42%)

TMUS T-Mobile
$109.00 /

-3.44 (-3.06%)

Periodicals

The U.K. is to host the…

ShowHide Related Items >>

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

GSK GlaxoSmithKline
$37.92 /

-0.065 (-0.17%)

PFE Pfizer
$36.22 /

-0.04 (-0.11%)

MRNA Moderna
$66.61 /

-2.12 (-3.08%)

JNJ Johnson & Johnson
$144.88 /

+0.7 (+0.49%)

NVAX Novavax
$103.15 /

-8.49 (-7.60%)

BNTX BioNTech
$64.17 /

-2.83 (-4.22%)

INO Inovio
$15.88 /

-1.07 (-6.31%)

AZN AstraZeneca
$55.85 /

+0.41 (+0.74%)

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

09/21/20 Piper Sandler
Regeneron’s Libtayo delivered results on par with Keytruda, says Piper Sandler
09/14/20 Roth Capital
Immunic has ‘significant’ opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
GSK GlaxoSmithKline
$37.92 /

-0.065 (-0.17%)

05:23 Today Oddo BHF
GlaxoSmithKline upgraded to Buy from Neutral at Oddo BHF
09/18/20 Societe Generale
GlaxoSmithKline price target raised to 2,350 GBp at Societe Generale
09/08/20 JPMorgan
GlaxoSmithKline price target lowered to 1,650 GBp from 1,700 GBp at JPMorgan
09/01/20 AlphaValue
GlaxoSmithKline upgraded to Buy from Add at AlphaValue
PFE Pfizer
$36.22 /

-0.04 (-0.11%)

09/21/20 Morgan Stanley
Eli Lilly’s Verzenio ‘clear winner’ over Pfizer’s Ibrance, says Morgan Stanley
09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause ‘a mixed blessing for Moderna, others, says SVB Leerink
MRNA Moderna
$66.61 /

-2.12 (-3.08%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause ‘a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$144.88 /

+0.7 (+0.49%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
NVAX Novavax
$103.15 /

-8.49 (-7.60%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings ‘compelling’ buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives ‘validation’ for vaccine candidate
BNTX BioNTech
$64.17 /

-2.83 (-4.22%)

09/09/20 SVB Leerink
AstraZeneca pause ‘a mixed blessing for Moderna, others, says SVB Leerink
09/08/20 B. Riley FBR
Novavax selloff brings ‘compelling’ buying opportunity, says B. Riley FBR
09/04/20 SVB Leerink
SVB Leerink positive on BioNTech’s adding fifth COVID-19 vaccine trial
08/27/20 Chardan
Moderna vaccine showed differentiation from BioNTech/Pfizer’s, says Chardan
INO Inovio
$15.88 /

-1.07 (-6.31%)

09/17/20 Roth Capital
Inovio Covid vaccine has ‘virtually no chance,’ says Roth Capital
09/09/20 Benchmark
Inovio LOI ‘effectively puts to bed’ doubts about manufacturing, says Benchmark
08/11/20 Stifel
Inovio price target lowered to $16 from $24 at Stifel
08/11/20 Cantor Fitzgerald
Inovio price target lowered to $31 from $45 at Cantor Fitzgerald
AZN AstraZeneca
$55.85 /

+0.41 (+0.74%)

05:21 Today Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees ‘no readthrough’ to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause ‘a mixed blessing for Moderna, others, says SVB Leerink
SNY Sanofi
$50.60 /

+0.7 (+1.40%)

GSK GlaxoSmithKline
$37.92 /

-0.065 (-0.17%)

PFE Pfizer
$36.22 /

-0.04 (-0.11%)

MRNA Moderna
$66.61 /

-2.12 (-3.08%)

JNJ Johnson & Johnson
$144.88 /

+0.7 (+0.49%)

NVAX Novavax
$103.15 /

-8.49 (-7.60%)

BNTX BioNTech
$64.17 /

-2.83 (-4.22%)

INO Inovio
$15.88 /

-1.07 (-6.31%)

AZN AstraZeneca
$55.85 /

+0.41 (+0.74%)

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

GSK GlaxoSmithKline
$37.92 /

-0.065 (-0.17%)

PFE Pfizer
$36.22 /

-0.04 (-0.11%)

MRNA Moderna
$66.61 /

-2.12 (-3.08%)

JNJ Johnson & Johnson
$144.88 /

+0.7 (+0.49%)

NVAX Novavax
$103.15 /

-8.49 (-7.60%)

BNTX BioNTech
$64.17 /

-2.83 (-4.22%)

INO Inovio
$15.88 /

-1.07 (-6.31%)

AZN AstraZeneca
$55.85 /

+0.41 (+0.74%)

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

GSK GlaxoSmithKline
$37.92 /

-0.065 (-0.17%)

PFE Pfizer
$36.22 /

-0.04 (-0.11%)

MRNA Moderna
$66.61 /

-2.12 (-3.08%)

JNJ Johnson & Johnson
$144.88 /

+0.7 (+0.49%)

NVAX Novavax
$103.15 /

-8.49 (-7.60%)

BNTX BioNTech
$64.17 /

-2.83 (-4.22%)

INO Inovio
$15.88 /

-1.07 (-6.31%)

AZN AstraZeneca
$55.85 /

+0.41 (+0.74%)

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

GSK GlaxoSmithKline
$37.92 /

-0.065 (-0.17%)

PFE Pfizer
$36.22 /

-0.04 (-0.11%)

MRNA Moderna
$66.61 /

-2.12 (-3.08%)

JNJ Johnson & Johnson
$144.88 /

+0.7 (+0.49%)

NVAX Novavax
$103.15 /

-8.49 (-7.60%)

BNTX BioNTech
$64.17 /

-2.83 (-4.22%)

INO Inovio
$15.88 /

-1.07 (-6.31%)

AZN AstraZeneca
$55.85 /

+0.41 (+0.74%)

Latest posts